Canada's SQI Diagnostics to Submit Celiac Array Panel to FDA, Debut Assay in Europe

After securing a Health Canada license for its second-generation test for celiac disease, the Toronto-based company now plans to submit the test to US regulators and launch it in Europe later this year.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.